What compounding actually means, what the FDA says about it, and how to tell a legitimate pharmacy from a dangerous one.
MedicalRecords.com gives you the facts on complicated healthcare topics. We don't sell or endorse any treatment — we want you to have honest information before you talk to your doctor.
Compounded semaglutide is not FDA-approved and carries significant quality risks. The FDA has issued warnings about adverse events. Only use compounded products from state-licensed 503B outsourcing facilities that undergo FDA inspections.
Compounded GLP-1s cost $200-$500/month vs $1,000-$1,500 for brand-name. The lower cost comes with real trade-offs: no standardized purity testing, inconsistent dosing, and no manufacturer liability if something goes wrong.
The FDA has warned about the dangers of compounded GLP-1 medications. These products are not FDA-approved and lack the safety, quality, and efficacy guarantees of brand-name drugs. Hospitalizations and serious adverse events have been reported.
Common misconception:
That "compounded semaglutide" is basically a generic version of Ozempic or Wegovy. It isn't.
System-level friction:
Compounded drugs aren't FDA-approved. They're only legally permitted when a drug is on the official shortage list. This gray area is where some providers cut corners.
The realistic picture:
The single most important thing to understand: FDA-approved drugs and compounded versions are fundamentally different products with different risk profiles.
Three scenarios where people encounter compounded GLP-1s, and the risks that come with each.
People with a prescription for a GLP-1 that's currently on the FDA's official drug shortage list.
The only legally clear reason to use a compounded version. But quality and dosage can vary, and the FDA doesn't oversee the final product.
People who can't get or can't afford brand-name and are willing to accept the risks of a non-FDA-approved product.
Cheaper and easier to access than brand-name. The tradeoff is real risk to your health — unknown purity, unknown potency, unknown sterility.
People who aren't comfortable with the risks of unregulated medication.
The safest path. You trade access to a specific molecule for the certainty that what you're taking has been tested and verified.
End of access pathways comparison. Each pathway has been presented with equal weight. No pathway is recommended over another.
Use these official resources to check shortage status and pharmacy credentials.
Users who want to verify if a specific medication is on the official shortage list
Free
Instant
This is an informational option card. No specific provider is being recommended.
Users considering a compounding pharmacy who want to check its licensing and any public disciplinary actions
Free
Instant
This is an informational option card. No specific provider is being recommended.
The FDA has explicitly warned about the potential dangers of unlawfully marketed and poor-quality compounded GLP-1s. Compounded drugs are not FDA-approved and do not have the same safety, quality, and efficacy guarantees.
Be cautious of providers that exhibit these warning signs:
This section provides regulatory context, warning signs for questionable providers, and a clear statement of MedicalRecords.com services and limitations.
It's a gray area. Federal law allows compounding pharmacies to make compounded versions of FDA-approved drugs when those drugs are on the official FDA shortage list. When the brand-name drug isn't in shortage, compounding it may not be legal. State laws add another layer of complexity.
No. Both may contain semaglutide, but Ozempic is FDA-approved and went through years of safety and efficacy testing with strict manufacturing controls. Compounded semaglutide has none of that oversight. Purity, potency, and sterility can all vary.
Inconsistent dosing. Contamination. Different salt forms (like semaglutide sodium) that may not behave the same as the approved drug. No FDA safety checks. No recourse if something goes wrong. The FDA has documented serious adverse events from compounded GLP-1 products.
Because compounding pharmacies skip the FDA approval process — the years of clinical trials, the manufacturing standards, the safety monitoring. Lower cost comes at the expense of the quality guarantees that FDA approval provides.
Check if it's licensed in your state through the state board of pharmacy. Look for accreditation from the Pharmacy Compounding Accreditation Board (PCAB). Be wary of pharmacies that operate only online, don't require prescriptions, or price their products far below market.
Semaglutide base is the form in FDA-approved products like Ozempic and Wegovy. Semaglutide sodium is a different salt form some compounding pharmacies use. The FDA has flagged semaglutide sodium as not equivalent to the approved form — it hasn't been evaluated for safety or efficacy in humans.
No. State boards of pharmacy handle licensing and regulation. The FDA can take action against compounding pharmacies that break federal law (like operating as unlicensed drug manufacturers). PCAB accreditation is voluntary and signals higher quality standards, but it's not universal.
Safer, FDA-regulated alternatives worth exploring:
Understanding eligibility:
Compounded medications carry real risks: inconsistent quality, contamination, wrong dosing, and unknown long-term effects. The FDA has issued public warnings specifically about compounded GLP-1 products.
MedicalRecords.com strongly urges patients to discuss all treatment options with a qualified healthcare provider. We don't sell, endorse, or facilitate access to compounded medications. This information is here so you can make informed decisions about your health.
